DEUTSCHE BANK AG\ - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 94 filers reported holding CUE BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$5,403
-95.0%
2,349
-89.5%
0.00%
Q1 2022$108,000
-59.2%
22,300
-4.8%
0.00%
Q4 2021$265,000
-20.4%
23,435
+2.6%
0.00%
Q3 2021$333,000
-10.0%
22,835
-28.0%
0.00%
Q2 2021$370,000
+6.3%
31,725
+11.4%
0.00%
Q1 2021$348,000
-26.1%
28,490
-24.3%
0.00%
Q4 2020$471,000
+29.0%
37,651
+55.3%
0.00%
Q3 2020$365,000
-17.4%
24,246
+34.5%
0.00%
Q2 2020$442,000
+333.3%
18,032
+151.6%
0.00%
Q1 2020$102,000
-10.5%
7,167
-1.1%
0.00%
Q4 2019$114,000
+147.8%
7,244
+25.8%
0.00%
Q3 2019$46,000
-62.6%
5,760
-58.3%
0.00%
Q2 2019$123,000
-29.7%
13,809
-39.5%
0.00%
Q1 2019$175,000
+63.6%
22,823
-1.2%
0.00%
Q4 2018$107,000
-84.4%
23,094
-69.5%
0.00%
Q3 2018$684,000
-6.9%
75,646
+22.0%
0.00%
Q2 2018$735,000
+362.3%
62,004
+442.5%
0.00%
Q1 2018$159,00011,4290.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Prosight Management, LP 1,510,282$7,370,0004.76%
SANDERS MORRIS HARRIS LLC 873,021$4,261,0000.83%
P.A.W. CAPITAL CORP 150,000$732,0000.76%
Nantahala Capital Management 2,244,359$10,952,0000.48%
Bleichroeder LP 552,000$2,694,0000.48%
APOGEM CAPITAL LLC 111,259$543,0000.37%
Slate Path Capital LP 1,483,619$7,240,0000.37%
Robertson Stephens Wealth Management, LLC 478,500$2,335,0000.20%
CARLSON CAPITAL L P 405,000$1,976,0000.14%
Bridgefront Capital, LLC 19,968$97,0000.12%
View complete list of CUE BIOPHARMA INC shareholders